Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,436.00    6.00 (0.14%)
Bid:
4,434.00
Ask:
4,438.00
Spread: 4.00 (0.09%)
Market Cap: £2.07b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Trading Update

2 Nov 2022 07:00

RNS Number : 9874E
Morgan Sindall Group PLC
02 November 2022
 

 

2 November 2022

 

 

Morgan Sindall Group plc

 

Trading Update

Morgan Sindall Group plc ("the Group") today provides an update on current trading and the outlook for the 2022 financial year.

Group performance and outlook

Since the time of the half year results on 4 August 2022, increased general market uncertainty together with continued inflationary headwinds have provided for a more challenging economic backdrop. Notwithstanding this, trading across the Group has been robust and with its high-quality secured workload giving good forward visibility, the Group is on track to deliver a full year performance in line with its expectations.

Trading has been as expected in Construction & Infrastructure. The Construction activities are expected to deliver an operating margin for the full year within its target range of 2.5%-3% and the operating margin in the Infrastructure activities is also expected to be within its target range of 3.5%-4%.

Fit Out's continued focus on operational delivery and customer experience, together with its order book for the rest of the year, means it is well-placed to deliver a very strong full year performance.

In Property Services, contract phasing and mobilisations is, as anticipated, driving slightly higher second half activity, although its operating margin continues to be impacted by general cost and labour inflation.

Partnership Housing has experienced a recent reduction in sales activity in line with the rest of the UK housing industry, however its focus on long-term partnerships with the public sector provides forward visibility and resilience. Average capital employed for the year is expected to be c£190m-£200m.

Urban Regeneration's active development schemes have progressed to plan, however inflation and interest rate increases are providing some scheme viability challenges. Average capital employed for the year is expected to be c£90m-£95m.

There has been no change to the previously announced estimate of building safety costs and the costs of applying the principles of the Building Safety Developer's Pledge across Partnership Housing and Urban Regeneration. These are still expected to be in the range of £40m-£50m and will be shown separately as exceptional provisions/expenses in the appropriate period(s).

Group secured workload

The Group has a sizeable and high-quality workload. The total secured workload for the Group at 30 September 2022 was £8.8bn, up 2% from the year end position (up 3% from the half year).

Within this, the construction secured order book of £4.6bn was up 2% from the year end (down 1% from the half year) and the regeneration secured order book of £4.2bn was up 3% from the year end (up 8% from the half year). 

Balance sheet

The Group's balance sheet remains strong and in an uncertain trading environment, the holding of a significant cash balance is more of a competitive advantage than ever.

The average daily net cash for the period from 1 January to 28 October was £260m (of which £62m was held in jointly controlled operations or held for future payment to designated suppliers).

As previously guided at the time of the half year results, the average daily net cash for the full year is expected to be around £250m.

In addition, the Group has significant undrawn bank facilities available to it. These total £180m, of which £165m mature in 2025 and £15m in 2024.

John Morgan, Chief Executive, said:

"In recent months, increased general market uncertainty together with continued inflationary headwinds have provided for a more challenging economic backdrop.

Despite this, trading across the Group has been robust and with our high-quality secured workload giving good forward visibility, we're on track to deliver a full year performance in line with our expectations."

ENDS

 

Morgan Sindall Group

John Morgan

Steve Crummett

 

Instinctif Partners

Matthew Smallwood

Bryn Woodward

Tel: 020 7307 9200

 

 

 

Tel: 020 7457 2020

Note to Editors

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.2bn, employing around 7,200 employees and operating in the public, regulated and private sectors. It reports through five divisions of Construction & Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFSMFAFEESESF
Date   Source Headline
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights
2nd Jun 202511:14 amRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.